Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
GA.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
GA.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
GA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBB.1.5.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
XBB.1.5.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
XBB.1.5.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GB.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GB.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used